Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population

Clinical Research in Cardiology

Volumn 106, Issue 2, 2017, Pages 96-104

  Bossard, Matthias ^a,b,c   Thériault, Sébastien ^c,d   Aeschbacher, Stefanie ^a   Schoen, Tobias ^a   Kunz, Seraina ^a   von Rotz, Mirco ^a   Estis, Joel ^e   Todd, John ^e   Risch, Martin ^f,g   Mueller, Christian ^a   Risch, Lorenz ^f,h,i   Paré, Guillaume ^c,d   Conen, David ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b HAMILTON GENERAL HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e SINGULEX INC   (United States)

^f Labormedizinisches Zentrum Dr Risch   (Liechtenstein)

^g KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ Private University   (Liechtenstein)

Author keywords

Age; B type natriuretic peptide; Blood pressure; Epidemiology; Heritability; Hypertrophy; Sex; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; TROPONIN I; BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HEART LEFT VENTRICLE MASS; HEART RATE; HERITABILITY; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; QUALITY CONTROL; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; GENETICS; HEREDITY; MULTIVARIATE ANALYSIS; NONLINEAR SYSTEM; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGE FACTORS; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEALTHY VOLUNTEERS; HEREDITY; HUMANS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; TROPONIN I;

EID: 84982253710     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-016-1026-5     Document Type: Article

References (39)

1. Wu AH, Christenson RH (2013) Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care. Clin Biochem 46(12):969–978. doi:10.1016/j.clinbiochem.2013.04.013
2. Giannitsis E, Katus HA (2013) Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 10(11):623–634. doi:10.1038/nrcardio.2013.129
3. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA J Am Med Assoc 304(22):2503–2512. doi:10.1001/jama.2010.1768
4. Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, Forastiere F, Wienhues-Thelen UH, Block D, Zaugg C, Vago T, Boccanelli A, study P (2013) High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 273(3):306–317. doi:10.1111/joim.12023
5. Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, Woodward M, Struthers A, Hughes M, Kee F, Salomaa V, Kuulasmaa K, Blankenberg S, Investigators M (2014) High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 35(5):271–281. doi:10.1093/eurheartj/eht406
6. Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, Hoogeveen RC, Sharrett AR, Ballantyne CM, Coresh J (2014) Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation 130(16):1374–1382. doi:10.1161/CIRCULATIONAHA.114.010815
7. Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV (2012) Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem 58(5):930–935. doi:10.1373/clinchem.2011.179176
8. Eggers KM, Venge P, Lindahl B, Lind L (2013) Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 61(18):1906–1913. doi:10.1016/j.jacc.2012.12.048
9. Neumann JT, Havulinna AS, Zeller T, Appelbaum S, Kunnas T, Nikkari S, Jousilahti P, Blankenberg S, Sydow K, Salomaa V (2014) Comparison of three troponins as predictors of future cardiovascular events—prospective results from the FINRISK and BiomaCaRE studies. PLoS One 9(3):e90063. doi:10.1371/journal.pone.0090063
10. Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JS, Nygard S, Hveem K, Rosjo H (2015) Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT study. Clin Chem. doi:10.1373/clinchem.2014.234369
11. Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL, Group BDS (2015) Troponin and Cardiac events in stable ischemic heart disease and diabetes. N Engl J Med 373(7):610–620. doi:10.1056/NEJMoa1415921
12. Aeschbacher S, Schoen T, Bossard M, van der Lely S, Glattli K, Todd J, Estis J, Risch M, Mueller C, Risch L, Conen D (2014) Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults. Am J Hypertens. doi:10.1093/ajh/hpu226
13. Sinning C, Keller T, Zeller T, Ojeda F, Schluter M, Schnabel R, Lubos E, Bickel C, Lackner KJ, Diemert P, Munzel T, Blankenberg S, Wild PS, Gutenberg Health S (2014) Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study. Clin Res Cardiol Off J German Cardiac Soc 103(3):211–222. doi:10.1007/s00392-013-0640-8
14. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA (2014) Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 63(14):1441–1448. doi:10.1016/j.jacc.2013.12.032
15. Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jorgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K, BiomarCa REI (2016) Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. doi:10.1093/eurheartj/ehw172
16. Conen D, Schon T, Aeschbacher S, Pare G, Frehner W, Risch M, Risch L (2013) Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors (GAPP). Swiss Med Week 143:w13728. doi:10.4414/smw.2013.13728
17. Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, Goix P (2007) Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 53(11):1990–1995
18. Bossard M, Pumpol K, van der Lely S, Aeschbacher S, Schoen T, Krisai P, Lam T, Todd J, Estis J, Risch M, Risch L, Conen D (2015) Plasma endothelin-1 and cardiovascular risk among young and healthy adults. Atherosclerosis 239(1):186–191. doi:10.1016/j.atherosclerosis.2014.12.061
19. Krisai P, Aeschbacher S, Schoen T, Bossard M, van der Stouwe JG, Dorig L, Todd J, Estis J, Risch M, Risch L, Conen D (2015) Glucagon-like peptide-1 and blood pressure in young and healthy adults from the general population. Hypertension 65(2):306–312. doi:10.1161/HYPERTENSIONAHA.114.04718
20. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, Investigators C-E (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20–29. doi:10.1056/NEJMoa1114248
21. American Diabetes Association (2012) Standards of medical care in diabetes–2012. Diabetes Care 35(Suppl 1):S11–S63. doi:10.2337/dc12-s011
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575. doi:10.1086/519795
23. Yang J, Lee SH, Goddard ME, Visscher PM (2011) GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88(1):76–82. doi:10.1016/j.ajhg.2010.11.011
24. McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS (2013) Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 59(7):1099–1107
25. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, Wians F, Sabatine MS, Morrow DA, de Lemos JA (2006) Prevalence and determinants of troponin T elevation in the general population. Circulation 113(16):1958–1965. doi:10.1161/CIRCULATIONAHA.105.609974
26. Eggers KM, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, Venge P, Lindahl B (2008) Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 29(18):2252–2258. doi:10.1093/eurheartj/ehn327
27. Gidding SS, Liu K, Colangelo LA, Cook NL, Goff DC, Glasser SP, Gardin JM, Lima JA (2013) Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Imaging 6(5):769–775. doi:10.1161/CIRCIMAGING.112.000450
28. Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, Cruikshank A, Reid A, Stoddart M, Strachan F, Walker S, Collinson PO, Apple FS, Gray AJ, Fox KA, Newby DE, Mills NL (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 350:g7873. doi:10.1136/bmj.g7873
29. Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C, Investigators T-A (2016) Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T—Sub-analysis from the TRAPID-AMI study. Int J Cardiol 209:26–33. doi:10.1016/j.ijcard.2016.01.213
30. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J, Thyroid Studies C (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA J Am Med Assoc 304(12):1365–1374. doi:10.1001/jama.2010.1361
31. Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ (2012) Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Intervent 5(2):270–278. doi:10.1161/CIRCINTERVENTIONS.111.966226
32. Wildi K, Haaf P, Reichlin T, Acemoglu R, Schneider J, Balmelli C, Drexler B, Twerenbold R, Mosimann T, Reiter M, Mueller M, Ernst S, Ballarino P, Zellweger C, Moehring B, Vilaplana C, Freidank H, Mueller C (2013) Uric acid for diagnosis and risk stratification in suspected myocardial infarction. Eur J Clin Invest 43(2):174–182. doi:10.1111/eci.12029
33. Pennell DJ, Porter JB, Piga A, Lai Y, El-Beshlawy A, Belhoul KM, Elalfy M, Yesilipek A, Kilinc Y, Lawniczek T, Habr D, Weisskopf M, Zhang Y, Aydinok Y, Investigators Cs (2014) A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). Blood 123(10):1447–1454. doi:10.1182/blood-2013-04-497842
34. Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T, St Hilaire C, Shanahan C (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 35(23):1515–1525. doi:10.1093/eurheartj/ehu163
35. Wang F, Ye P, Luo L, Xu R, Bai Y, Wu H (2012) Association of glomerular filtration rate with high-sensitivity cardiac troponin T in a community-based population study in Beijing. PLoS One 7(5):e38218. doi:10.1371/journal.pone.0038218
36. Stacy SR, Suarez-Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED (2014) Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med 161(7):502–512. doi:10.7326/M14-0746
37. Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, deFilippi CR, O’Donnell CJ, Kathiresan S, Rice K, Heckbert SR, Ballantyne CM, Psaty BM, Boerwinkle E, Consortium CA (2013) Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circulation Cardiovascular genetics 6(1):82–88. doi:10.1161/CIRCGENETICS.112.963058
38. Bella JN, Goring HH (2012) Genetic epidemiology of left ventricular hypertrophy. Am J Cardiovasc Dis 2(4):267–278
39. Conen D, Zeller A, Pfisterer M, Martina B (2006) Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 97(2):249–252. doi:10.1016/j.amjcard.2005.08.028